<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04798157</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-03-04</org_study_id>
    <nct_id>NCT04798157</nct_id>
  </id_info>
  <brief_title>Transcranial Doppler in Children With Hemoglobinopathies</brief_title>
  <official_title>Role of Transcranial Doppler (TCD) in Children With Hemoglobinopathies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transcranial Doppler ultrasonography (TCD) is a noninvasive, portable technique for&#xD;
      evaluating the intracranial vasculature.&#xD;
&#xD;
      TCD ultrasonography is performed placing a low frequency (â‰¤ 2 MHz) transducer on the scalp of&#xD;
      the patient, in order to visualize the intracranial arterial vessels through specific&#xD;
      acoustic windows, where bone is thinner, and evaluate cerebral blood flow velocity (CBFV) .&#xD;
&#xD;
      Patients diagnosed to have hemoglobinopathy conditions with its most common forms thalassemia&#xD;
      and sickle cell disease manifest both biochemical and clinical evidence of hypercoagulability&#xD;
      conditions include deep venous thrombosis, pulmonary emboli and recurrent arterial occlusion&#xD;
      .&#xD;
&#xD;
      Cerebrovascular accidents can be identified using transcranial Doppler ultrasonography which&#xD;
      enables evaluation of cerebral artery blood flow velocity with a sensitivity of 90% and&#xD;
      specificity of 100 % when compared with cerebral angiography .&#xD;
&#xD;
      According to the stroke prevention trial in sickle cell anemia (STOP) study ,TCDs were&#xD;
      classified based on blood velocity in the circle of Willis, expressed as time averaged mean&#xD;
      of the maximum velocity (TAMMV). Children with abnormal, high velocities (&gt;200cm/s) were at&#xD;
      increased risk of stroke, which was reduced by 90% after starting regular blood transfusions.&#xD;
      TAMMVs less than 170cm/s were classified as normal with annual TCD scanning recommended,&#xD;
      whereas velocities between 170 and 200cm/s were called conditional, and followed up more&#xD;
      closely without starting transfusion.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2021</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the blood flow velocities at the circle of Willis</measure>
    <time_frame>At procedure exam time</time_frame>
    <description>The children will be be subjected to Transcranial Doppler (TCD ) , and velocity indices will be obtained , the subjects will be classified according the TAMMV (time average mean maximum velocities ) into high risk group with TAMMV &gt; 200 cm/sec , and normal group &lt;170 cm/sec , and conditional group with TAMMV 170-200 cm/sec .</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hemoglobinopathies</condition>
  <arm_group>
    <arm_group_label>Children with Hemoglobinopathies</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>children from 2-18 years old , diagnosed to have hemoglobinopathy disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>transcranial doppler</intervention_name>
    <description>Transcranial Doppler ultrasonography will be done using the ultrasound machine by placing a transducer over the relatively thinner temporal and occipital bones in order to visualize and evaluate the velocities at the circle of Willis.</description>
    <arm_group_label>Children with Hemoglobinopathies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  children diagnosed with hemoglobinopathies&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children before two years old .&#xD;
&#xD;
          -  Hemoglobinopathy patients more than 18 years .&#xD;
&#xD;
          -  Uncooperative patients .&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed E. Mohamed, ass. teacher</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of medicine Sohag university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed E. Mohamed, ass. teacher</last_name>
    <phone>+201030826466</phone>
    <email>mohammad.albadry2012@gmail.com</email>
  </overall_contact>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>March 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2021</study_first_posted>
  <last_update_submitted>March 12, 2021</last_update_submitted>
  <last_update_submitted_qc>March 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Mohamed Ahmed Elbadry Mohamed</investigator_full_name>
    <investigator_title>teaching assistant , faculty of medicine , Sohag university</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemoglobinopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

